HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
about
CDK11 complexes promote pre-mRNA splicingComparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKsHIV-1 Tat interacts with LIS1 proteinTat gets the "green" light on transcription initiationNuclear protein phosphatase-1 regulates HIV-1 transcriptionProtein phosphatase-1 dephosphorylates the C-terminal domain of RNA polymerase-IIAntiviral activity of CYC202 in HIV-1-infected cellsSNPs in the HIV-1 TATA box and the AIDS pandemic.The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients.A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllersp53 Interacts with RNA polymerase II through its core domain and impairs Pol II processivity in vivo.Network-based prediction and analysis of HIV dependency factorsViralPhos: incorporating a recursively statistical method to predict phosphorylation sites on virus proteins.Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription.Inhibition of PP2A by LIS1 increases HIV-1 gene expression.Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription.A novel binding pocket of cyclin-dependent kinase 2.The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.Identifying protein phosphorylation sites with kinase substrate specificity on human viruses.Recent progress in the discovery and development of cyclin-dependent kinase inhibitors.Iron chelators ICL670 and 311 inhibit HIV-1 transcription.HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem CellsCDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90.Role of cellular iron and oxygen in the regulation of HIV-1 infection.Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev.Retroviral proteomics and interactomes: intricate balances of cell survival and viral replication.Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.Regulation of HIV-1 transcription at 3% versus 21% oxygen concentrationRegulation of CDK9 activity by phosphorylation and dephosphorylation.Analysis of the roles of HIV-derived microRNAs.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.A CDK2 activity signature predicts outcome in CDK2-low cancers.A novel anticancer agent ARC antagonizes HIV-1 and HCV.Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein.RNA polymerase II C-terminal heptarepeat domain Ser-7 phosphorylation is established in a mediator-dependent fashion.T-Cell Signaling in HIV-1 Infection.HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription.Post-translational Modification-Based Regulation of HIV Replication
P2860
Q24337666-4B63AF9C-5AFF-4939-B629-77CB39996696Q24796929-B460DB9F-DBC0-4DAE-BCC4-61A034B020FBQ24807276-1EA1846E-0BF5-4514-A6E9-D4707927B1B5Q24815711-D15F32AB-0674-4688-84DB-826353C939DBQ28177130-5AB6D2F8-E043-4A83-99EE-3769288868C2Q28218480-3D22DF61-F448-44D1-92F1-AC08E8AD1F87Q28292152-43929839-09E4-4701-A3E7-40290724E7C3Q30390434-063C7531-6BAA-40E5-A07F-DE2038E71F0AQ33626049-07AC3270-DC43-46E4-AA8D-E648673D522DQ33811660-DDA4FB49-9AA7-4954-9907-538A13F6889AQ33988333-DAA4DFF5-4C6F-4403-A1A5-225178E47519Q34037645-14F3E5E5-603D-44F8-971D-E40B0774D872Q34406358-027C96B8-1AE4-4F03-9E6D-33B33219B416Q34537015-F0DD8CD5-042F-404A-987F-948AC5ED163DQ34619456-B0BA4AC9-FEF2-41B3-A474-B9CA57372297Q35098682-A5A6167B-0274-4A75-8AE6-CECFAB923531Q35131134-12A7376D-7BFC-4AC8-A271-9D107F301801Q35835565-6CED6C92-C69D-4760-9C2E-E4BFE0B88363Q35888903-8BC89758-9164-4FB6-8948-861B160EC92EQ36109734-1315FD3C-E2F8-46EE-ABAB-536544CEEFD6Q36120794-3B8D3079-6AF2-45C2-B718-02A9391D2115Q36143645-E8979E92-119F-4855-AE0F-A00F4BC0721FQ36190162-F2756350-AAA6-4129-812A-05E8D6897039Q36448119-934A25B6-2DD9-4C66-915F-5A6DA9EC74EDQ36839068-9443ACFB-B7C6-469F-847B-F9D6A6F40E94Q36895615-75FCA49D-942E-45DB-8F33-B18AC4BCD8E7Q37183096-2219D0F4-FAAC-47BB-B58A-52CC83C35136Q37397177-838F131C-B864-411E-80E3-72F5021D194FQ37423506-001D3734-E44E-4869-9FC2-E7403E387481Q37553804-B7B609E8-4C6B-4518-BC2A-B8E663BDB5C6Q37816443-8873D8CC-A310-41E1-AC32-4BE3198D7050Q38212101-189F890A-391F-46DE-91A8-6757D1121C60Q38662748-101350DF-D7EB-4D9F-93BA-6305F1376490Q39209798-F74AFB89-3643-4A6B-AC93-19F67AA125B9Q40195173-2EE445A6-7E39-4E70-AFAB-458FC02056E4Q40379930-383D1E8A-E170-4CFA-AB0E-A43BA402A3BEQ42099538-508582A2-068B-42E8-8C1E-EE81C6E74D0BQ42273481-F97BEC76-A95F-4E4B-96DF-C75AF9B5BC90Q55220272-CFA57D6D-C9BB-46B1-BF4F-4912E801C5EBQ58750447-2553260E-493D-44BA-9AE7-28B0FFF6C8FA
P2860
HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
HIV-1 Tat interaction with RNA ...... scription from HIV-1 promoter.
@en
HIV-1 Tat interaction with RNA polymerase II C-terminal domain
@nl
type
label
HIV-1 Tat interaction with RNA ...... scription from HIV-1 promoter.
@en
HIV-1 Tat interaction with RNA polymerase II C-terminal domain
@nl
prefLabel
HIV-1 Tat interaction with RNA ...... scription from HIV-1 promoter.
@en
HIV-1 Tat interaction with RNA polymerase II C-terminal domain
@nl
P2093
P2860
P356
P1476
HIV-1 Tat interaction with RNA ...... scription from HIV-1 promoter.
@en
P2093
Anne Pumfery
Fatah Kashanchi
Longwen Deng
Sergei Nekhai
Tatyana Ammosova
P2860
P304
33922-33929
P356
10.1074/JBC.M111349200
P407
P577
2002-07-11T00:00:00Z